The Dispensary Method in Preventive Medicine
Proactive Orientation and Operational Forms
The dispensary method occupies a distinctive position within preventive medicine because it does not wait for patients to present with symptoms. Instead, it organizes healthcare around the principle of active outreach — identifying individuals at risk or already affected, enrolling them in structured programmes of monitoring and support, and intervening before conditions deteriorate or complications arise. This proactive orientation distinguishes dispensarization from ordinary clinical care, where the encounter is typically initiated by the patient rather than by the health system.
The method encompasses three operational forms. Preventive dispensarization targets apparently healthy individuals identified as carrying elevated risk — pregnant women, children during developmental milestones, workers exposed to occupational hazards, and elderly individuals facing age-related transitions. The goal is to detect risk factor accumulation and intervene before disease manifests. Post-treatment dispensarization focuses on individuals who have passed through an acute illness episode and now require systematic follow-up to prevent recurrence, manage residual impairments, and support recovery. Comprehensive dispensarization seeks to combine both approaches across entire populations, representing the most ambitious expression of the dispensary philosophy, though it demands corresponding organizational capacity and sustained resource commitment.
Methodological Elements and Organizational Settings
Dispensarization operates through two principal methodological elements. The first is non-specific secondary prevention, delivered through various forms of medical examination: mass preventive examinations conducted at predictable life transitions such as school entry, employment commencement, and university enrolment; the annual preventive examination in general practice; targeted examinations for individuals with known risk factors; and periodic examinations for those living with established chronic conditions. The second element is screening — standardized testing protocols applied to asymptomatic populations to detect disease at stages when treatment is most likely to be effective. These two elements complement one another: examinations provide the organizational framework for periodic contact with defined population groups, while screening enables detection of specific diseases through validated tests applied systematically.
The organizational settings for dispensarization reflect the diversity of clinical needs. Outpatient medical establishments handle common chronic conditions and risk factor management, where proximity and continuity of care support regular surveillance. Hospital facilities contribute where specialist assessment or advanced diagnostics are required. Complex Oncology Centers assume full responsibility for malignant disease surveillance, integrating multidisciplinary expertise with cancer registry functions, clinical trials, and community prevention work. Centers for Mental Health provide comprehensive psychiatric care including emergency responses, psychotherapy, psychosocial rehabilitation, and home care delivery for those unable to attend facility-based services. Centers for Skin and Venereal Diseases combine dermatological management with sexually transmitted infection control, serving both individual patients and broader public health objectives.
Voluntarism, Regulation, and Coordination
Dispensarization is voluntary and contingent upon informed consent. The general practitioner has a formal obligation to provide the patient with detailed information about the nature and severity of the condition, its potential complications, the surveillance and treatment methods available, and the risks of declining follow-up — and to document the patient’s decision. Exceptions to voluntarism apply when illness creates conditions for criminal behaviour, when the affected individual poses demonstrable danger to others, or when compulsory treatment is the only viable means of protecting public health. These exceptions are narrowly defined in health legislation and do not override the general presumption of voluntary participation.
Several regulatory principles govern the organization of dispensarization to prevent duplication and ensure coordination. No individual may be enrolled for the same condition at more than one facility simultaneously. For children under eighteen, when comorbid conditions fall within the same disease class but require different providers, the specialist assumes responsibility for all conditions in that class. For adults, the general practitioner typically retains integrated responsibility, except for insulin-dependent diabetes and specialist post-operative cardiac follow-up during the first year. The minimum duration for any preventive examination is fifteen minutes — a floor below which meaningful clinical assessment cannot realistically occur. When a patient is enrolled for multiple conditions with differing examination frequencies, the highest prescribed frequency governs the overall surveillance schedule; for diagnostic tests required across multiple programmes, the maximum frequency for any specific investigation applies rather than summing requirements across programmes.
Health Groups and Performance Assessment
Individuals entering dispensarization are classified into five groups according to health status and disease severity. Group I comprises healthy individuals with no objective clinical findings or complaints — children under seven years, active athletes, and pregnant women. Group II encompasses practically healthy individuals who carry elevated risk for disease development: significant cardiovascular risk factors, risk factors for type 2 diabetes, risk factors for malignancies of the cervix, breast, colorectum, or prostate, and conditions such as obesity, physical inactivity, or habitual tobacco use. Group III consists of chronically ill individuals with compensated disease — mild clinical manifestations, infrequent exacerbations, and largely preserved work capacity. Group IV includes those with subcompensated disease, characterized by moderate functional impairment and frequent exacerbations requiring periodic intensive medical attention. Group V comprises individuals with decompensated disease, where permanent functional disability necessitates continuous medical supervision. These groups provide a structured language for tracking health trajectories over time and for organizing the intensity of surveillance accordingly.
Physicians conducting dispensarization prepare annual stage summaries documenting disease dynamics over the surveillance period, the effects of therapeutic and rehabilitation interventions, and outstanding needs. The performance of dispensarization programmes is assessed through quantitative indicators. Timeliness measures the proportion of newly diagnosed cases that are enrolled in dispensarization promptly after diagnosis. Systematic observation quantifies adherence to scheduled surveillance among enrolled individuals. Outcome indicators include recovery rates, improvement rates, stability rates, and deterioration rates — all expressed as proportions of the total dispensarized population. Mortality may be reported as a simple proportion or as a rate using person-time denominators. A coverage target of not less than forty-five percent of eligible adults for annual preventive examinations serves as a minimum quality benchmark. Clinical targets for specific conditions include HbA1c below 7.0 percent and blood pressure below 140/85 mm Hg for at least half the surveillance period in non-insulin-dependent diabetes management, and LDL cholesterol below 1.8 mmol/l for patients with ischaemic heart disease within cardiovascular surveillance programmes.